4 mg retatrutide Dosage: Week-to-Week Schedule & Chart Retatrutide | Metabolic Research Peptides

The timeline from drug discovery to FDA approval typically takes 10-15 years

95% CI, 0.36-0.61), ovarian cancer (HR = 0.52

Louis show in a new study that GLP-1 medications may be effective at treating and preventing substance use disorders across all major addictive substances studied, suggesting these drugs target a common biological pathway underlying addiction

Put your phone in front of you with a countdown running

And on the horizon, with an FDA decision expected by April 10, 2026, is orforglipron, Eli Lilly's next-generation oral GLP-1 that could reshape the entire landscape of medically assisted weight management